arXiv AI
Aug 18

FZ-VLM: A Two Stage Florence-Zephyr Vision Language Model Framework for Pulmonary Nodule Characterization and Clinical Decision Making

arXiv:2608. 15004v1 Announce Type: cross Abstract: Lung cancer remains one of the leading causes of cancer-related mortality worldwide, and Computed Tomography (CT) is a primary imaging tool for screening and followup assessment.

By Pramit Dutta, Jenita Manokaran, Richa Mittal, Ryan Appleby, Eranga Ukwatta
arXiv Machine Learning
Jul 2

Foundation Models vs. Radiomics for Lung Computed Tomography: A Benchmark of Feature Extractors, Classification Heads, and Segmentation Choices

arXiv:2607. 01001v1 Announce Type: cross Abstract: Radiomics is the established approach for CT-based lung cancer phenotyping, yet comparisons with foundation models rarely isolate contributions of feature extractor, classification head, and segmentation choice, or test cross-cohort robustness.

By Nils Neukirch, Martin Maurer, Nils Strodthoff
arXiv AI
Aug 18

Comprehensive Benchmarking of Deep Learning Architectures for Lung Cancer Histopathology

arXiv:2608. 15915v1 Announce Type: cross Abstract: Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination.

By Hadi Hasan, Safaa Salman, Lama Sleem, Ralph Mouawad, Ali Chehab
arXiv Machine Learning
Sep 11

Artificial Intelligence Algorithms for the Detection of Pathologies Related to Lung Cancer through Image Analysis using Convolutional Neural Networks and Data Augmentation: a systematic mapping of the literature

The article reviews recent applications of artificial intelligence and deep learning, particularly convolutional neural networks with transfer learning and data augmentation, for detecting lung cancer in medical images. It surveys 96 studies from 2015 onward, highlighting high sensitivity and specificity achieved by these methods. The authors also identify challenges such as data standardization, model explainability, patient privacy, and ethical concerns that must be addressed before clinical deployment.

By Pablo Ramirez Amador